1. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment
   Naveed Ullah Khan et al, 2021, Acta Pharmaceutica Sinica B CrossRef
2. Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
   Giovanni Luca Beretta et al, 2017, European Journal of Medicinal Chemistry CrossRef
3. Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway
   Yun-Suk Kwon et al, 2021, Biochemical Pharmacology CrossRef
4. Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy
   Masoom Raza et al, 2021, Molecular and Cellular Biochemistry CrossRef
5. Crosstalk between Wnt signaling and Phorbol ester-mediated PKC signaling in MCF-7 human breast cancer cells
   Soyoung Kim et al, 2016, Biomedicine & Pharmacotherapy CrossRef
6. Metformin selectively targets 4T1 tumorspheres and enhances the antitumor effects of doxorubicin by downregulating the AKT and STAT3 signaling pathways
   Yun‑Suk Kwon et al, 2018, Oncology Letters CrossRef
7. Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology
   Farnaz Barneh et al, 2018, Journal of Cellular Biochemistry CrossRef
8. Programmable Delivery of Synergistic Cancer Drug Combinations Using Bicompartmental Nanoparticles
   Jason V. Gregory et al, 2020, Advanced Healthcare Materials CrossRef
9. Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer
   Roberto Ruiu et al, 2021, Cancers CrossRef
10. Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advances
    Sven Marcel Stefan et al, 2019, Medicinal Research Reviews CrossRef
11. Tocopherol-human serum albumin nanoparticles enhance lapatinib delivery and overcome doxorubicin resistance in breast cancer
    Milan Paul et al, 2024, Nanomedicine CrossRef
12. Macromolecular crowding in the development of a three-dimensional organotypic human breast cancer model
    Naledi Shologu et al, 2022, Biomaterials CrossRef
13. Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage
    Meghna Mehta et al, 2021, International Journal of Radiation Biology CrossRef
14. Integrated Design of a Membrane‐Lytic Peptide‐Based Intravenous Nanotherapeutic Suppresses Triple‐Negative Breast Cancer
    Charles H. Chen et al, 2022, Advanced Science CrossRef
15. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases
    Jiang Ni et al, 2021, Journal of Controlled Release CrossRef
16. MMP9-Sensitive PEG-Shedding Nanoliposomes for Targeted Codelivery of Erlotinib and Doxorubicin to MDA-MB-231 Cells
    So-Yeon Kim et al, 2021, ACS Applied Polymer Materials CrossRef
17. Lapatinib enhances paclitaxel toxicity in MCF-7, T47D, and MDA-MB-321 breast cancer cells
    Alicja Zajdel et al, 2021, Toxicology in Vitro CrossRef